Immunization with DNA vaccines in early life: advantages and limitations as compared to conventional vaccines.
Siegrist
C A
CA
Department of Pathology, University of Geneva, Switzerland.
Lambert
P H
PH
D000328:Adult; D000818:Animals; D000831:Animals, Newborn; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000008:administration & dosage; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007107:Immune System / Q000254:growth & development; D007108:Immune Tolerance; D007112:Immunity, Maternally-Acquired; D007115:Immunization Schedule; D007223:Infant; D007231:Infant, Newborn / Q000276:immunology*; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D008222:Lymphokines / Q000378:metabolism; D051379:Mice; D012449:Safety; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000378:metabolism; D019444:Vaccines, DNA / Q000008:administration & dosage*; D014765:Viral Vaccines / Q000008:administration & dosage
D001428:Bacterial Vaccines; D008222:Lymphokines; D019444:Vaccines, DNA; D014765:Viral Vaccines